Legal Representation
Attorney
Barry F. Soalt
USPTO Deadlines
Next Deadline
16 days remaining
NOA E-Mailed - SOU Required
Due Date
August 18, 2025
Extension Available
Until February 18, 2026
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 26, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 26, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 26, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 26, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 26, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 7, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 16, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 3, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 3, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 3, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 30, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 29, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Apr 29, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 5, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Feb 5, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 5, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 5, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 30, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jan 30, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jan 30, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Dec 29, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 28, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 28, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 26, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 26, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 28, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 28, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 28, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 27, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 3, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 22, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for the treatment of viral and infectious diseases, allergies, diabetes, and for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood, weight, pregnancy and immune system related diseases and disorders, all for the purpose of integrating digital and biopharmaceutical therapeutics to increase health-span and life-span for all humanity
Class 042
Pharmaceutical product development services; Pharmaceutical research services
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOVENTURES"